XBIOTECH INC. Increase (Decrease) in Income Taxes Receivable
XBIOTECH INC. (XBIT) reported Increase (Decrease) in Income Taxes Receivable of $14.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxesReceivable · last filed 2026-08-13
- XBIOTECH INC. increase (decrease) in income taxes receivable for the quarter ending 2025-12-31 was -$151.00K, a 988.24% decline year-over-year.
- XBIOTECH INC. increase (decrease) in income taxes receivable for the quarter ending 2025-09-30 was -$83.00K, a 561.11% decline year-over-year.
- XBIOTECH INC. increase (decrease) in income taxes receivable for the quarter ending 2024-12-31 was $17.00K.
- XBIOTECH INC. increase (decrease) in income taxes receivable for the quarter ending 2024-09-30 was $18.00K.
- XBIOTECH INC. increase (decrease) in income taxes receivable for fiscal 2025 was -$234.00K, a 381.93% decline from fiscal 2024.
- XBIOTECH INC. increase (decrease) in income taxes receivable for fiscal 2024 was $83.00K.
- XBIOTECH INC. increase (decrease) in income taxes receivable for fiscal 2023 was -$473.00K.
- XBIOTECH INC. increase (decrease) in income taxes receivable for fiscal 2022 was -$8.56M, a 459.50% decline from fiscal 2021.
| Period end | Increase (Decrease) in Income Taxes Receivable 3 month | Increase (Decrease) in Income Taxes Receivable 6 month | Increase (Decrease) in Income Taxes Receivable 9 month | Increase (Decrease) in Income Taxes Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $14.00K 10-Q · filed 2026-08-13 | |||
| 2025-12-31 | -$151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$234.00K derived: sum of 2 quarters · filed 2026-03-13 | -$234.00K 10-K · filed 2026-03-13 | |
| 2025-09-30 | -$83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$83.00K 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | |||
| 2024-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $35.00K derived: sum of 2 quarters · filed 2026-03-13 | $83.00K 10-K · filed 2026-03-13 | |
| 2024-09-30 | $18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $66.00K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $48.00K 10-Q · filed 2025-08-13 | |||
| 2023-12-31 | -$376.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$502.00K derived: sum of 2 quarters · filed 2025-03-18 | -$473.00K derived: sum of 3 quarters · filed 2025-03-18 | -$473.00K 10-K · filed 2025-03-18 |
| 2023-09-30 | -$126.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$97.00K derived: sum of 2 quarters · filed 2024-11-13 | -$97.00K 10-Q · filed 2024-11-13 | -$876.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $29.00K 10-Q · filed 2024-08-12 | -$750.00K derived: sum of 3 quarters · filed 2024-08-12 | -$12.00M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | -$779.00K derived: sum of 2 quarters · filed 2024-03-15 | -$12.03M derived: sum of 3 quarters · filed 2024-03-15 | -$9.63M derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-12-31 | -$779.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$12.03M derived: sum of 2 quarters · filed 2024-03-15 | -$9.63M derived: sum of 3 quarters · filed 2024-03-15 | -$8.56M 10-K · filed 2024-03-15 |
| 2022-09-30 | -$11.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$8.85M derived: sum of 2 quarters · filed 2023-11-09 | -$7.78M 10-Q · filed 2023-11-09 | -$9.22M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $3.47M 10-Q · filed 2023-08-11 | $2.03M derived: sum of 3 quarters · filed 2023-08-11 | $4.32M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $1.07M 10-Q · filed 2023-05-10 | -$369.00K derived: sum of 2 quarters · filed 2023-05-10 | $1.92M derived: sum of 3 quarters · filed 2023-05-10 | $6.68M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $845.00K derived: sum of 2 quarters · filed 2023-03-15 | $5.61M derived: sum of 3 quarters · filed 2023-03-15 | $2.38M 10-K · filed 2023-03-15 |
| 2021-09-30 | $2.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $7.05M derived: sum of 2 quarters · filed 2022-11-09 | $3.82M 10-Q · filed 2022-11-09 | $4.29M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $4.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $1.53M 10-Q · filed 2022-08-10 | $2.00M derived: sum of 3 quarters · filed 2022-08-10 | $3.13M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | -$3.23M 10-Q · filed 2022-05-10 | -$2.76M derived: sum of 2 quarters · filed 2022-05-10 | -$1.63M derived: sum of 3 quarters · filed 2022-05-10 | -$444.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $464.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $1.60M derived: sum of 2 quarters · filed 2022-03-15 | $2.78M derived: sum of 3 quarters · filed 2022-03-15 | $6.57M 10-K · filed 2022-03-15 |
| 2020-09-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $2.32M derived: sum of 2 quarters · filed 2021-11-09 | $6.11M 10-Q · filed 2021-11-09 | $6.11M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | $1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $4.97M 10-Q · filed 2021-08-09 | $4.97M derived: sum of 3 quarters · filed 2022-03-15 | $4.97M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | $3.79M 10-Q · filed 2021-05-10 | $3.79M derived: sum of 2 quarters · filed 2022-03-15 | $3.79M derived: sum of 3 quarters · filed 2022-03-15 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $0.00 derived: sum of 2 quarters · filed 2022-03-15 | $0.00 10-K · filed 2022-03-15 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-10 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |